18F-Fluoride Uptake in Soft Tissue Metastases of Medullary Thyroid Carcinoma as a Marker of Progressive Calcification

Show simple item record

dc.contributor Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.author DUARTE, Paulo Schiavom FMUSP-HC
MARIN, Jose Flavio Gomes FMUSP-HC
dc.date.issued 2018
dc.identifier.citation CLINICAL NUCLEAR MEDICINE, v.43, n.11, p.848-849, 2018
dc.identifier.issn 0363-9762
dc.identifier.uri http://observatorio.fm.usp.br/handle/OPI/29425
dc.description.abstract F-18-fluoride (F-18-NaF) uptake in soft tissue metastases of medullary thyroid carcinoma (MTC) has been reported. However, the evolution of these metastatic sites has rarely been assessed. We present a case of F-18-NaF uptake in multiple liver metastases of MTC initially without macroscopic calcification. The CT follow-up studies showed a progressive calcium deposition in the lesions. Therefore, this case suggests that the F-18-NaF uptake in MTC metastases could potentially be a marker of an ongoing calcification process instead of an inert deposit of calcium.
dc.language.iso eng
dc.relation.ispartof Clinical Nuclear Medicine
dc.rights restrictedAccess
dc.subject F-18; F-18-NaF; calcification; medullary thyroid carcinoma; metastases; PET; CT
dc.subject.other f-18-naf pet/ct; f-18-fluoride pet/ct; back-pain; cancer
dc.title 18F-Fluoride Uptake in Soft Tissue Metastases of Medullary Thyroid Carcinoma as a Marker of Progressive Calcification
dc.type article
dc.rights.holder Copyright LIPPINCOTT WILLIAMS & WILKINS
dc.description.group LIM/43
dc.identifier.doi 10.1097/RLU.0000000000002259
dc.identifier.pmid 30179909
dc.type.category editorial material
dc.type.version publishedVersion
hcfmusp.author DUARTE, Paulo Schiavom:HC:ICESP
hcfmusp.author MARIN, Jose Flavio Gomes:HC:ICESP
hcfmusp.author COURA FILHO, George Barberio:HC:ICESP
hcfmusp.author SAPIENZA, Marcelo Tatit:FM:MDR
hcfmusp.author BUCHPIGUEL, Carlos Alberto:FM:MDR
hcfmusp.origem.id WOS:000447734700029
hcfmusp.origem.id 2-s2.0-85054437379
hcfmusp.publisher.city PHILADELPHIA
hcfmusp.publisher.country USA
hcfmusp.relation.reference · Al-Zaghal A, 2018, CLIN NUCL MED, V43, pE278, DOI 10.1097/RLU.0000000000002164
· Blomberg BA, 2017, EUR J NUCL MED MOL I, V44, P249, DOI 10.1007/s00259-016-3552-9
· do Vale RHB, 2015, CLIN NUCL MED, V40, P895, DOI 10.1097/RLU.0000000000000939
· Derlin T, 2011, J NUCL MED, V52, P362, DOI 10.2967/jnumed.110.081208
· Duarte PS, 2018, NUCL MED MOLEC IMAG, V52, P318, DOI 10.1007/s13139-018-0527-8
· Duarte PS, 2018, CLIN NUCL MED, V43, P623, DOI 10.1097/RLU.0000000000002163
· Joshi NV, 2014, LANCET, V383, P705, DOI 10.1016/S0140-6736(13)61754-7
· MCCOOK TA, 1982, AM J ROENTGENOL, V139, P149, DOI 10.2214/ajr.139.1.149
· Shao FQ, 2016, CLIN NUCL MED, V41, P902, DOI 10.1097/RLU.0000000000001367
· Shao FQ, 2016, CLIN NUCL MED, V41, P815, DOI 10.1097/RLU.0000000000001343
· WILLIAMS ED, 1966, J CLIN PATHOL, V19, P103, DOI 10.1136/jcp.19.2.103
· Zhu Y, 2017, CLIN NUCL MED, V42, P154, DOI 10.1097/RLU.0000000000001483
dc.description.index MEDLINE
dc.identifier.eissn 1536-0229
hcfmusp.citation.scopus 2
hcfmusp.citation.wos 2

Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


My Account